HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $573 | +5.9% | 15 | 0.0% | 0.00% | – |
| Q2 2023 | $541 | -54.3% | 15 | -51.6% | 0.00% | – |
| Q1 2023 | $1,184 | -32.9% | 31 | 0.0% | 0.00% | – |
| Q4 2022 | $1,764 | +76.4% | 31 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 31 | +19.2% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 26 | -13.3% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 30 | -42.3% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 52 | +23.8% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 42 | -37.3% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +50.0% | 67 | -2.9% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 69 | +53.3% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 45 | -22.4% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |